Generic name:durvalumab [ dur-VAL-ue-mab ]
Drug class:Anti-PD-1 monoclonal antibodies
What is Imfinzi?
Imfinzi is a cancer medicine that works with your immune system to interfere with the growth and spread of cancer cells in the body.
Imfinzi is used to treat non-small cell lung cancer in patients whose tumors cannot be removed by surgery, and whose cancer has not progressed after treatment with chemotherapy and radiation (chemoradiation).
Imfinzi is also used to treat small cell lung cancer in combination with the chemotherapy medicines etoposide and carboplatin or cisplatin when the cancer has spread within your lungs or to other parts of the body.
Warnings
Imfinzi works by causing your immune system to attack tumor cells. Durvalumab may cause your immune system to attack healthy organs and tissues in your body. This could lead to serious or life-threatening side effects on your lungs, liver, pancreas, kidneys, intestines, thyroid, pituitary, or adrenal glands.
Call your doctor at once if you have new or unusual symptoms, such as: tiredness, mood changes, headaches, vision problems, muscle weakness, stomach problems, weight changes, skin rash, hair loss, bleeding or bruising, yellowing of your skin or eyes, increased or decreased urination, dark urine, bloody or tarry stools, worsening cough, chest pain, or trouble breathing.
Before taking this medicine
You should not use Imfinzi if you are allergic to durvalumab.
To make sure Imfinzi is safe for you, tell your doctor if you have have an active infection, or if you have ever had:
